Related Experiment Videos
Antigenic structure of ovarian cancer metastases
P G Prokopenko1, S A Borisenko, A A Terent'ev
1Department of Biochemistry, Russian State Medical University, Moscow.
Abstract:
Twenty highly specific (organ-specific and tumor-associated) antigens named ovarian metastatic antigens were revealed using polyclonal antibodies isolated from rabbits after immunization with soluble antigens from ovarian cancer metastases. These protein antigens were not detected by precipitating test system (sensitivity 1 mg/liter) in tissues of adult humans (except for organ-specific antigens) and blood plasma from healthy donors. Ovarian metastatic antigens included organ-specific, placenta-specific, tumor embryonic, tumor-associated, and reactive proteins. The precipitating test system identified 15 antigens in the amniotic fluid from pregnant women and 7 antigens in the plasma from patients with ovarian cancer (incidence 16-75%).
Insights
Researchers identified twenty ovarian metastatic antigens specific to ovarian cancer. These antigens were found in amniotic fluid and ovarian cancer patient plasma, not in healthy donors, aiding cancer diagnostics.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Ovarian cancer diagnosis often relies on late-stage detection.
- Identifying specific biomarkers for early detection and targeted therapy is crucial.
Purpose of the Study:
- To identify and characterize novel organ-specific and tumor-associated antigens in ovarian cancer metastases.
- To evaluate the presence of these antigens in biological fluids for diagnostic potential.
Main Methods:
- Immunization of rabbits with soluble antigens from ovarian cancer metastases.
- Isolation of polyclonal antibodies specific to ovarian cancer antigens.
- Utilizing a precipitating test system to detect antigen presence in human tissues, blood plasma, and amniotic fluid.
Main Results:
- Twenty highly specific ovarian metastatic antigens were identified.
- These antigens were largely absent in healthy adult tissues and plasma, except for organ-specific ones.
- Fifteen antigens were detected in amniotic fluid, and seven in ovarian cancer patient plasma (16-75% incidence).
Conclusions:
- Ovarian metastatic antigens represent a promising class of biomarkers for ovarian cancer.
- Their presence in amniotic fluid and patient plasma suggests potential for non-invasive diagnostic applications.
- Further research is warranted to explore their role in ovarian cancer pathogenesis and therapeutic targeting.